Paul Clark
Chief Executive Officer en Lilly ICOS LLC .
Perfil
El Sr. Paul N. Clark es director independiente de Agenus, Inc., director principal independiente no ejecutivo de Keysight Technologies, Inc. y director independiente de Agilent Technologies, Inc. y presidente y director ejecutivo de Lilly ICOS LLC. Forma parte del Consejo de Administración de Agenus, Inc., Keysight Technologies, Inc. y Grifols Therapeutics, Inc. Anteriormente, el Sr. Clark fue director independiente de Amylin Pharmaceuticals, Inc., socio operativo de Genstar Capital LLC, presidente de ICOS Corp., director y vicepresidente ejecutivo de Abbott Laboratories, vicepresidente de ventas y marketing de Marion Laboratories y socio operativo y asesor de Genstar Capital Management LLC. También formó parte del consejo de administración de BIOLASE, Inc, Talecris Biotherapeutics Holdings Corp, Catalent Pharma Solutions, Inc, Cerevast Neurorehab, Inc y Harlan Laboratories, Inc. Se licenció en la Universidad de Alabama y obtuvo un MBA en la Tuck School of Business de Dartmouth.
Cargos activos de Paul Clark
| Empresas | Cargo | Inicio |
|---|---|---|
Lilly ICOS LLC
 Lilly ICOS LLC Pharmaceuticals: MajorHealth Technology Lilly ICOS LLC develops and markets medical drugs. It produces Cialis drug which is used for the treatment of erectile dysfunction. The firm's competitors are Viagra and Levitra. The company was founded in October 1998 and is headquartered in Indianapolis, IN. | Chief Executive Officer | - |
Grifols Therapeutics, Inc.
 Grifols Therapeutics, Inc. BiotechnologyHealth Technology Grifols Therapeutics, Inc. specialized in the pharmaceutical-hospital services. The company was founded on March 7, 2005 and is headquartered in Research Triangle Park, NC. | Director/Board Member | 27/10/2011 |
Antiguos cargos conocidos de Paul Clark.
| Empresas | Cargo | Fin |
|---|---|---|
| AGILENT TECHNOLOGIES, INC. | Director/Board Member | 21/12/2021 |
| KEYSIGHT TECHNOLOGIES, INC. | Chairman | 01/10/2019 |
| AGENUS INC. | Director/Board Member | 15/06/2021 |
| BIOLASE, INC. | Chairman | 01/09/2017 |
Catalent Pharma Solutions, Inc.
 Catalent Pharma Solutions, Inc. Pharmaceuticals: MajorHealth Technology Catalent Pharma Solutions, Inc. engages in the development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Development and Clinical Services, Oral Technologies, and Medication Delivery Solutions. The Development and Clinical Services segment manufactures, packs, stores distributes, and manages inventory for global clinical trials of drugs and biologics. The Oral Technologies segment formulates, develops, and manufactures prescription and consumer health products using various technologies. The Medication Delivery Solutions segment develops, formulates, and manufactures prefilled syringes and other injectable formats. The company was founded in 2002 and is headquartered in Somerset, NJ. | Director/Board Member | 01/09/2014 |
Formación de Paul Clark.
| The University of Alabama | Undergraduate Degree |
| Tuck School of Business at Dartmouth | Masters Business Admin |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 6 |
|---|---|
| ABBOTT LABORATORIES | Health Technology |
| BIOLASE, INC. | Health Technology |
| AGILENT TECHNOLOGIES, INC. | Health Technology |
| AGENUS INC. | Health Technology |
| KEYSIGHT TECHNOLOGIES, INC. | Electronic Technology |
| CATALENT, INC. | Health Technology |
| Empresas privadas | 11 |
|---|---|
Amylin Pharmaceuticals, Inc.
 Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | Health Technology |
ICOS Corp.
 ICOS Corp. Pharmaceuticals: OtherHealth Technology ICOS Corp. manufactures medications to treat inflammation and other serious diseases. It focuses on the development of treatments for unmet medical conditions such as prostatic hyperplasia, hypertension, pulmonary arterial hypertension, cancer, and inflammatory diseases. The company was founded in 1989 by Christopher Henney and George Rathman and is headquartered in Bothell, WA. | Health Technology |
Genstar Capital Management LLC
 Genstar Capital Management LLC Investment ManagersFinance Genstar Capital Management LLC is a private equity firm founded in 1988 by Dennis H. Chookaszian. The firm is headquartered in San Francisco., California. | Finance |
Lilly ICOS LLC
Lilly ICOS LLC Pharmaceuticals: MajorHealth Technology Lilly ICOS LLC develops and markets medical drugs. It produces Cialis drug which is used for the treatment of erectile dysfunction. The firm's competitors are Viagra and Levitra. The company was founded in October 1998 and is headquartered in Indianapolis, IN. | Health Technology |
Cerevast Medical, Inc.
 Cerevast Medical, Inc. Investment ManagersFinance Cerevast Neurorehab, Inc. operates as neuroscience medical device technology company. It develops a therapy for the treatment of acute ischemic stroke. The firm offers ClotBust-ER, an operator independent device, which helps in administering ultrasound energy for sonothrombolysis therapy. The company was founded in 2009 and is headquartered in Redmond, WA. | Finance |
Grifols Therapeutics, Inc.
Grifols Therapeutics, Inc. BiotechnologyHealth Technology Grifols Therapeutics, Inc. specialized in the pharmaceutical-hospital services. The company was founded on March 7, 2005 and is headquartered in Research Triangle Park, NC. | Health Technology |
Talecris Biotherapeutics Holdings Corp.
 Talecris Biotherapeutics Holdings Corp. BiotechnologyHealth Technology Talecris Biotherapeutics Holdings Corp. develops and markets plasma-derived protein therapy products. The company was founded in 1942 and is headquartered in Research Triangle Park, NC. | Health Technology |
Catalent Pharma Solutions, Inc.
Catalent Pharma Solutions, Inc. Pharmaceuticals: MajorHealth Technology Catalent Pharma Solutions, Inc. engages in the development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Development and Clinical Services, Oral Technologies, and Medication Delivery Solutions. The Development and Clinical Services segment manufactures, packs, stores distributes, and manages inventory for global clinical trials of drugs and biologics. The Oral Technologies segment formulates, develops, and manufactures prescription and consumer health products using various technologies. The Medication Delivery Solutions segment develops, formulates, and manufactures prefilled syringes and other injectable formats. The company was founded in 2002 and is headquartered in Somerset, NJ. | Health Technology |
| Marion Laboratories | Distribution Services |
Harlan Laboratories, Inc.
 Harlan Laboratories, Inc. Miscellaneous Commercial ServicesCommercial Services Harlan Laboratories, Inc. provided essential, pre-clinical and non-clinical contract research, research models, lab animal diets and services. The firm's focused on providing customers with products and services to optimize the discovery and safety of new medicines and compounds. The company was founded in 1931 and was headquartered in Indianapolis, IN. | Commercial Services |
Genstar Capital LLC
 Genstar Capital LLC Investment ManagersFinance Genstar Capital LLC engages in provision of investment consulting services. It offers investment advice to financial services, healthcare, industrial, and technology and software industries. The company was founded in 1988 and is headquartered in San Francisco, CA. | Finance |
- Bolsa de valores
- Insiders
- Paul Clark
